REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $643,000 | +54.6% | 25,600 | +86.9% | 0.00% | +50.0% |
Q2 2022 | $416,000 | -55.3% | 13,700 | +48.3% | 0.00% | -33.3% |
Q3 2021 | $930,000 | -32.7% | 9,235 | -5.5% | 0.00% | -40.0% |
Q2 2021 | $1,382,000 | -63.7% | 9,768 | -74.4% | 0.01% | -70.6% |
Q1 2021 | $3,803,000 | +37.6% | 38,140 | +70.6% | 0.02% | +41.7% |
Q4 2020 | $2,764,000 | -25.7% | 22,355 | -48.7% | 0.01% | -14.3% |
Q1 2019 | $3,722,000 | -5.6% | 43,543 | -38.1% | 0.01% | -22.2% |
Q4 2018 | $3,944,000 | – | 70,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |